| Primary |
| Hiv Infection |
75.3% |
| Product Used For Unknown Indication |
8.6% |
| Hypertension |
3.8% |
| Drug Exposure During Pregnancy |
2.3% |
| Acquired Immunodeficiency Syndrome |
1.0% |
| Prophylaxis |
1.0% |
| Antifungal Prophylaxis |
0.9% |
| Lymph Node Tuberculosis |
0.8% |
| Asthma |
0.7% |
| Depression |
0.7% |
| Pneumonia |
0.6% |
| Drug Use For Unknown Indication |
0.6% |
| Rash |
0.6% |
| Anxiety |
0.5% |
| Cardiac Failure Congestive |
0.5% |
| Opportunistic Infection Prophylaxis |
0.5% |
| Pain |
0.5% |
| Herpes Simplex |
0.4% |
| Insomnia |
0.4% |
| Kaposi's Sarcoma |
0.4% |
|
| Viral Load Increased |
17.7% |
| Rash |
9.8% |
| Drug Resistance |
7.0% |
| Abortion Spontaneous |
6.5% |
| Vomiting |
5.9% |
| Renal Failure Acute |
5.3% |
| Renal Failure |
4.2% |
| Thrombocytopenia |
4.2% |
| Rhabdomyolysis |
3.9% |
| Depression |
3.7% |
| Gynaecomastia |
3.7% |
| Pancreatitis |
3.7% |
| Suicidal Ideation |
3.7% |
| Anaemia |
3.4% |
| Hypersensitivity |
3.1% |
| Stillbirth |
3.1% |
| Liver Function Test Abnormal |
2.8% |
| Nausea |
2.8% |
| Neutropenia |
2.8% |
| Paraesthesia |
2.8% |
|
| Secondary |
| Hiv Infection |
42.8% |
| Product Used For Unknown Indication |
13.8% |
| Antiretroviral Therapy |
8.0% |
| Drug Exposure During Pregnancy |
6.9% |
| Hypertension |
5.8% |
| Maternal Exposure Timing Unspecified |
5.6% |
| Antiviral Treatment |
2.3% |
| Pathogen Resistance |
1.8% |
| Sciatica |
1.3% |
| Antifungal Prophylaxis |
1.2% |
| Depression |
1.1% |
| Hiv Infection Cdc Category A2 |
1.1% |
| Insomnia |
1.1% |
| Intentional Drug Misuse |
1.1% |
| Maternal Exposure During Pregnancy |
1.1% |
| Meningitis Tuberculous |
1.1% |
| Mycobacterium Avium Complex Infection |
1.1% |
| Factor Viii Deficiency |
1.0% |
| Pain |
1.0% |
| Hepatitis C |
0.9% |
|
| Abortion Spontaneous |
14.2% |
| Drug Exposure During Pregnancy |
12.1% |
| Nightmare |
6.4% |
| Factor Viii Inhibition |
5.0% |
| Nephrolithiasis |
5.0% |
| Premature Baby |
5.0% |
| Vomiting |
5.0% |
| Caesarean Section |
4.3% |
| Foetal Exposure During Pregnancy |
4.3% |
| Nausea |
4.3% |
| Neutropenia |
4.3% |
| Cytolytic Hepatitis |
3.5% |
| Maternal Exposure During Pregnancy |
3.5% |
| Pelvic Kidney |
3.5% |
| Renal Failure Acute |
3.5% |
| Renal Tubular Necrosis |
3.5% |
| Stevens-johnson Syndrome |
3.5% |
| Thrombocytopenia |
3.5% |
| Abortion Induced |
2.8% |
| Chest Pain |
2.8% |
|
| Concomitant |
| Hiv Infection |
34.0% |
| Product Used For Unknown Indication |
16.6% |
| Hepatitis C |
12.6% |
| Depression |
4.1% |
| Pain |
3.8% |
| Smoking Cessation Therapy |
3.8% |
| Hypertension |
3.5% |
| Drug Use For Unknown Indication |
3.3% |
| Medical Diet |
2.6% |
| Neuralgia |
2.0% |
| Hiv Test Positive |
1.8% |
| Insomnia |
1.7% |
| Bipolar Disorder |
1.5% |
| Anxiety |
1.4% |
| Sleep Disorder |
1.3% |
| Arthritis |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Respiratory Tract Irritation |
1.2% |
| Asthma |
1.1% |
| Nausea |
1.1% |
|
| Vomiting |
11.7% |
| Drug Ineffective |
9.0% |
| Weight Decreased |
9.0% |
| Rash |
6.3% |
| Renal Failure Acute |
5.4% |
| Influenza Like Illness |
4.5% |
| Stillbirth |
4.5% |
| Syncope |
4.5% |
| Violence-related Symptom |
4.5% |
| White Blood Cell Count Decreased |
4.5% |
| Drug Exposure During Pregnancy |
3.6% |
| Drug Interaction |
3.6% |
| Gastrointestinal Toxicity |
3.6% |
| Liver Function Test Abnormal |
3.6% |
| Malaise |
3.6% |
| Mental Disorder |
3.6% |
| Nausea |
3.6% |
| Off Label Use |
3.6% |
| Pain |
3.6% |
| Pneumonia |
3.6% |
|
| Interacting |
| Pulmonary Tuberculosis |
55.6% |
| Hiv Infection |
11.1% |
| Hiv Test Positive |
11.1% |
| Obesity |
11.1% |
| Fungal Infection |
5.6% |
| Smoking Cessation Therapy |
5.6% |
|
| Drug Interaction |
14.3% |
| Hallucination |
14.3% |
| Liver Function Test Abnormal |
14.3% |
| Thinking Abnormal |
14.3% |
| Viraemia |
14.3% |
| Viral Load Increased |
14.3% |
| Vomiting |
14.3% |
|
